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Exfoliative dermatitis or erythroderma in infancy is rare. Clinicians need to be alert to the possible
diagnosis of Omenn syndrome (OS), a rare form of combined immunodeﬁciency in infants presenting
with recurrent infections, erythroderma, lymphadenopathy, hepatosplenomegaly, eosinophilia, and
increased serum IgE levels. OS is fatal unless treated by hematopoietic stem cell transplantation.
We described a 26-day-old boy who had presented with diffusely thick scales on the scalp and some
pustules on his face and trunk since birth. The rash was initially treated as presumed seborrheic
dermatitis. At the age of 42 days, he developed extensive exfoliative dermatitis, lymphadenopathy,
hepatosplenomegaly, and failure to thrive as well as eosinophilia and increased serum IgE levels. The
histopathology of the skin and lymph node were consistent with the diagnosis of OS. He had been
prepared for allograft bone marrow transplantation twice at 5 months and 7 months of age, but the
procedure was not performed because of catheter-related sepsis. The patient eventually died of sepsis
secondary to perianal cellulitis at 20 months of age.
Copyright  2011, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Omenn syndrome (OS, OMIM 603554, http://www.ncbi.nlm.nih.
gov/omim/603554), a rare autosomal recessive disease, is charac-
terized by symptoms of severe combined immunodeﬁciency (SCID)
associated with erythroderma, hepatosplenomegaly, lymphade-
nopathy, and alopecia.1,2 Similar to other patients with SCID,
patients with OS typically present early in infancy with viral or
fungal pneumonitis, chronic diarrhea, and failure to thrive.
However, unlike typical SCID, patients with OS manifest eryth-
roderma, lymphadenopathy, eosinophilia, and increased IgE
levels.1,2 Clinical diagnostic criteria for OS have been previously
described as the clinical triad of hepatosplenomegaly, lymphade-
nopathy, and erythroderma in the absence of maternofetal
engraftment and presence of either a raised IgE or peripheral
eosinophil count, together with immunodeﬁciency.3 Mutations of
the recombination activating gene 1 and 2 (RAG1 and RAG2) have
been reported in most OS patients4,5 and result in the absence of
circulating B cells and nonfunctional oligoclonal T cells.4 Unless
treated with hematopoietic stem cell transplantation, OS patients
usually succumb early in life to overwhelming opportunisticlogy, National Cheng Kung
ng Li Road, Tainan, Taiwan.
).
iwanese Dermatological Associatioinfections. Herein, we report an OS case and the result of mutation
analysis.
Case report
A 26-day-old boy was born at full term as the ﬁrst child after an
uncomplicated pregnancy. There family history was unremarkable.
The baby weighed 2.4 kg at birth. Diffuse thick scaling starting from
the vertex of the scalp with progressive involvement of the fore-
head with some pustules on his face and trunk had been noted
since birth. He was admitted to our Pediatric ward 26 days after
birth with the diagnosis of seborrheic dermatitis associated with
secondary bacterial infection. The initial laboratory tests showed
eosinophilia (1035/mL) (white blood cell 6900/mL and lymphocytes
3519/mL), neutropenia (1380/mL), anemia (Hemoglobin 7.1 g/dL),
and hypoalbuminemia (2.6 g/dL). A pus culture yielded heavy
oxacillin-resistant Staphylococcus aureus and Neisseria subﬂava.
After being treated with systemic antibiotics and topical hydro-
cortisone acetate 1% ointment, yellowish crusts decreased and he
was discharged 1 week later.
At the age of 42 days, the child was admitted the Pediatric ward
again because of fever and vomiting. Physical examination revealed
generalized exfoliative dermatitis (Figure 1), alopecia, bilateral
axillary and inguinal lymphadenopathy, mild hepatomegaly, and
failure to thrive (weighed 2.92 kg, <3rd percentile). Microscopic
examination of the clipped hairs revealed no bamboo hair. Labo-
ratory tests revealed marked eosinophilia (2002/mL) (white bloodn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Two-month-old boy presented with generalized exfoliative dermatitis.
Figure 2 (AeC) The epidermis shows spongiotic psoriasiform spongiotic psoriasiform
hyperplasia with parakeratosis and inﬁltration of numerous small lymphocytes in the
spongiotic foci as well as focal vacuolar interface changes (hematoxylin and eosin;
original magniﬁcation for A: 40; B: 100). (C) The dermoepidermal interface is
obscured by the inﬁltration of small lymphocytes. Note the presence of a few single
necrotic keratinocytes (hematoxylin and eosin; original magniﬁcation 200).
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anemia (Hemoglobin 8.0 g/dL), and hypogammaglobulinemia. The
total serum IgE level was elevated (3289 IU/mL), whereas IgG
(273 mg/dL), IgA (<6.67 mg/dL), and IgM (32.5 mg/dL) levels were
all below the lower limits. The ﬂow cytometry showed a deﬁciency
of T lymphocytes: T cells were decreased (24%); B cells (CD19) were
increased (67%); natural killer cells were normal (7%) and T cells
showed an abnormal distribution of CD4 and CD8 (8% of CD4 and
8% of CD8).6 The chest X-ray revealed no obviously thymus aplasia.
A skin biopsy showed spongiotic psoriasiform hyperplasia with
parakeratosis and inﬁltration of numerous small lymphocytes in
the spongiotic foci as well as focal vacuolar interface changes
(Figures 2A and 2B). There was inﬁltration of small lymphocytes
obscuring the dermoepidermal interface with presence of a few
single necrotic keratinocytes (Figure 2C). The papillary dermis
showed extravasation of erythrocytes and a superﬁcial perivascular
and patchy lichenoid inﬁltrate consisting of small lymphocytes and
a small number of neutrophils. Immunostaining revealed that the
lymphocytes were CD3þ with about equal amounts of CD4þ and
CD8þ cells in the inﬁltrate. The ﬁndings were compatible with OS
but differed somewhat from those of the typical OS, which usually
shows a predominance of CD4þ over CD8þ cells.4,7 A lymph node
biopsy revealed almost complete absence of germinal centers and
marked reduction of lymphocytes in the cortical and paracortical
areas where there was dense inﬁltrates of histiocytes and abundant
eosinophils. The immunohistochemical staining revealed that the
Figure 3 (A and B) A lymph node biopsy revealed almost complete absence of germinal centers and marked reduction of lymphocytes in the cortical and paracortical areas replaced
by histiocytes and abundant eosinophils (hematoxylin and eosin; original magniﬁcation A: 40; B: 100). (C) The immunohistochemical staining revealed the inﬁltrating
lymphocytes were CD3þ cells(original magniﬁcation 40). (D) CD20þ B cells were present in small foci in the residual primary lymphoid follicles (original magniﬁcation 40).
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CD8þ cells. CD20þ B cells were present in small foci in the residual
primary lymphoid follicles. Large numbers of S100-positive his-
tiocytoid cells were present in the cortical and paracortical areas
(Figure 3). The ﬁndings were consistent with OS.7e10
Mutation analysis of RAG1, RAG2, ARTEMIS, and SPINK5 were
performed. No mutation was identiﬁed in our patient and his
parents. In view of the clinical and laboratory ﬁndings, the clinical
diagnostic criteria of OS were reached and the patient had been
prepared for allograft bone marrow transplantation at the age of
5 months and 7 months. However, the transplantation was not
done because of catheter-related sepsis. Thirteen months later, the
patient died of sepsis secondary to perianal cellulitis.
Discussion
OS, originally reported as “familial reticuloendotheliosis with
eosinophilia” by Omenn1 in 1965, is a rare autosomal recessive
form of SCID. The frequency is 1:5,000,000 and the male to female
ratio is about 1. Clinically, OS manifests as exfoliative dermatitis,
followed by lymphadenopathy, hepatosplenomegaly, alopecia,
diarrhea, failure to thrive, and recurrent life-threatening infections.
Eighty percent of the patients present the clinical triad of former
three manifestations. In general, the onset is during the 1st day of
life and mostly before the age of 8 weeks.1,2,4
In the present case, the clinical and laboratory ﬁndings of hep-
atosplenomegaly, lymphadenopathy, erythroderma, alopecia,
recurrent severe infection, failure to thrive, eosinophilia, and
elevated IgE together with immunodeﬁciency met the diagnostic
criteria of OS despite that no mutation in RAG1, RAG2, and ARTEMIS
gene were identiﬁed in the patient and his parents. These resultsdid not change the diagnosis as OS is a genetically heterogeneous
condition and patients may have as yet unidentiﬁed gene defects.
The histopathology of the erythrodermic skin and lymph node was
also consistent with the diagnosis of OS.
Most OS cases show an autosomal recessive inheritance pattern
withmutations in the RAG1 or RAG2, which encode RAG1 and RAG2
enzymes. Normally, RAG1 and RAG2 enzymes, which are restricted
to immature lymphocytes, initiate a V (D) J (Variable, Diversity,
Joining) recombination that leads to both T- and B-cell develop-
ment. The absence of V (D) J recombination results in SCID, such as
OS.7,11,12 In OS, the defect in V (D) J recombination is partial and
characterized by presence of only a small number of T cell clones,
which inﬁltrate the skin, gut, liver, and spleen leading to clinical
manifestations. The number of peripheral blood lymphocytes can
be decreased, normal, or increased with variable B cell counts and
hypogammaglobulinemia. Recently, other studies suggested that
defects in genes other than RAGs, such as ARTEMIS, IL7RA, and
RNase mitochondrial RNA processing RNA gene may cause OS.13e15
Indeed, in a study of nine patients with clinical and immunological
features of OS, seven had no detectable mutations in the RAG or
ARTEMIS genes, suggesting that mutations in as yet undiscovered
genes may cause an immunodeﬁciency syndrome immunologically
and phenotypically similar to OS.3 A low to absent number of
CD19þ B cells is characteristic of OS associated with mutations in
RAG1, RAG2, ARTEMIS, or DNA ligase 4. However, B cells are normal
in other forms of OS without these mutations similar to our case.10
Pruszkowski et al16 conducted a retrospective study of 51 cases
of neonatal erythroderma. On average, the etiological diagnosis was
established 11 months after the onset of erythroderma. The
underlying causes observed included immunodeﬁciency (30%),
simple or complex ichthyosis (24%), Netherton syndrome (NS,
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dermatitis (20%).17 Atopic dermatitis and seborrheic dermatitis
were less frequent in neonatal erythroderma. Other causes of
erythroderma include fungal infections, graft-versus-host disease
(GVHD), and drug eruptions. The cause remains unknown in 10%.17
Differential diagnosis of erythrodermawith immunodeﬁciency and
failure to thrive in neonates lies mainly among OS, GVHD, and NS.
Clinical presentation in these neonates may be very similar;
therefore, blood investigation, skin biopsy, immunocytochemistry,
and molecular genetic analysis are needed to establish the diag-
nosis (Table 1).
GVHD can be present in newborns with SCID because of
maternal-fetal transfusion or as a consequence of blood trans-
fusion.18 Symptoms of maternal-fetal GVHD in SCID patients may
vary from a transient morbilliform eruption to erythroderma with
alopecia. NS is a rare severe autosomal recessive disease charac-
terized by congenital ichthyosiform erythroderma, ichthyosis lin-
earis circumﬂexa, “bamboo hair” (trichorrhexis invaginata), and
atopic diathesis with elevated IgE. Most patients with NS are
typically born with a generalized erythroderma, which can be
difﬁcult to distinguish clinically from other types of infantile
erythroderma initially. The erythroderma can persist throughout
life or evolve into a milder phenotype known as ichthyosis linearis
circumﬂexa. Diagnosis of NS may be delayed because the pathog-
nomic trichorrhexis invaginata or ichthyosis linearis circumﬂexa
often does not become evident until after the 1st year of life.19
Mutations in serine protease inhibitor Kazal-type 5 (SPINK5) have
been identiﬁed in NS. In this case, the mutation analysis of SPINK5
was negative.
Both GVHD and NS were excluded in the present case. OS and
GVHD can be differentiated histologically from NS by the presenceTable 1 Differential diagnosis of this case.
Disease Cause Cutaneous characteristics Extracu
Omenn
syndrome
Mutation in RAG 1/RAG 2
gene, rarely in IL-7R, RMPR,
or ARTEMIS gene
Erythroderma and alopecia Hepatos
lympha
hypopla
to thriv
infectio
sepsis, a
Maternal-fetal
GVHD
Persistence of maternal T
cells in patients with SCID
Variety (transient
morbilliform eruption to
erythroderma and alopecia)
Hepatop
transam
diarrhe
failure t
Netherton
syndrome
Mutation in SPINK-5 gene Erythroderma, alopecia,
later ichthyosis linearis
circumﬂexa, trichorrhexis
invaginata
Hyperte
Later: b
allergic
enterop
growth
infectio
Present case No mutation in SPINK-5,
RAG 1/RAG 2, and ARTEMIS
gene
Erythroderma and alopecia Hepatos
lympha
diarrhe
recurre
(pneum
sepsis, a
GVHD¼ graft-versus-host disease; IHC¼ immunohistochemistry; LCA¼ leukocyte commof epidermal basal vacuolization and apoptosis of keratino-
cytes.20,21 Both were present in the biopsy of our patient, thereby
making a diagnosis of NS highly unlikely. Furthermore, no bamboo
hairs were found. Skin biopsies in OS can look very similar to those
in GVHD. However, in OS, there is always acanthosis and para-
keratosis, whereas the epidermis in GVHD is generally ﬂat and
rarely with parakeratosis.21 Inﬂammation is more marked in OS,
with a high lymphocyte ⁄macrophage ratio, whereas in GVHD, this
ratio is between 1:1 and 1:4.8 Additional clinical ﬁndings, such as
eosinophilia and pronounced lymphadenopathy, can help to
differentiate the erythroderma in OS from GVHD. Genetic markers
may also be used to distinguish nonautologous cells from autolo-
gous cells.22
OS is fatal if untreated; the most frequent causes of death are
recurrent infections, particularly respiratory infections and septi-
cemia. Therapeutic options include bone marrow transplantation
or cord blood stem cell transplantation; however, the mortality is
still 46%. Early diagnosis of OS is very important to initiate appro-
priate treatment because OS is often rapidly fatal because of life-
threatening infections when bone marrow transplantation is
delayed.
In conclusion, we report a case of OS in a Taiwanese infant, in
which the diagnosis was established as early as 3 months of age.
Although the diagnosis had been made early enough for an early
allograft bone marrow transplantation, the procedure was unfor-
tunately aborted twice because of catheter-related sepsis. The child
eventually died of sepsis secondary to perianal cellulitis at the age
of 20 months. Clinicians should be familiar with the key clinical
ﬁndings of OS, which consist of neonatal erythrodermia, hep-
atosplenomegaly, and lymphadenopathy with recurrent life-
threatening infections and failure to thrive, and the characteristictaneous symptoms Diagnosis Histology20,21
plenomegaly,
denopathy, thymus
sia, diarrhea, failure
e, recurrent serious
ns (pneumonia,
nd so on)
Blood differential:
eosinophilia, IgE [,
infectious disease
diagnosis, lymphocyte
phenotyping, molecular
genetic analysis
Skin: always acanthosis,
almost always
parakeratosis,
predominantly
lymphocytic inﬁltrate (IHC
of LCA), dyskeratosis, basal
vacuolation
Lymph node: abnormal
architecture typically with
an absence of germinal
centers and paracortical
expansion of S100 staining
interdigitating reticulum
cells
athy (icterus,
inase elevation),
a, anemia, fever,
o thrive
Transaminases [, bilirubin
[, speciﬁc: chimerism
analysis for detection of
maternal lymphocytes
Skin: ﬂat epidermis, rarely
parakeratosis, dyskeratosis,
basal vacuolation, relatively
more macrophages in
inﬁltration (IHC of CD68).
nsive dehydration.
ronchial asthma,
rhinoconjunctivitis,
athy, delayed
, recurrent
ns
Hair shaft analysis, IHC
(LEKTI)
Skin: psoriasiform
acanthosis, thickening of
the basement membrane,
prominent dermal blood
vessels, a dermal inﬁltrate
with lymphocytes and
macrophages equally
represented.
plenomegaly,
denopathy,
a, failure to thrive,
nt serious infections
onia, abscess,
nd so on)
Eosinophilia, IgE [,
infectious disease diagnosis
Skin: spongiotic
psoriasiform hyperplasia
with parakeratosis and
vacuolar interface changes
with necrotic keratinocytes.
Lymph node: consistent
with OS.
on antigen; LEKTI¼ lymphoepithelial Kazal-type-related inhibitor.
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so that an early diagnosis could be established for bone marrow
transplantation in a timely fashion. Molecular diagnosis procedures
are nowavailable to determine the diagnosis or to serve as a tool for
genetic counseling and prenatal diagnosis.
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